Exosomal fibronectin and EGF like repeats and discoidin domains 3 (EDIL3) levels were markedly elevated in breast cancer patients compared to controls and sharply decreased following tumor resection, indicating that they could be crucial prognostic and diagnostic indicators for patients with breast cancer [193,194]. This evidence concerns the gene FN1 and breast cancer.